The Presence of Microplastics and Nanoplastics in the Humans Ileum, Colon, and Rectum and Their Relation With Inflammatory Bowel Disease (IBD)
Observational · No treatment assigned · Sites not listed yet · Pierpaolo Sileri
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: IBD. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Patients who will undergo any type of bowel surgery due to any type of clinical condition, as established by normal clinical practice, where colon, ileum and/or rectum resection is involved.
- Patients aged ≥ 18 years.
- Patients who have read, understood, accepted, and signed the informed consent to the study.
Plus 1 more requirement(s). There are also 3 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 102 participants are expected to take part.
- Start date: 2025-06 (planned).
- Main results expected around 2025-09-30 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Determination of the presence of microplastics and nanoplastics in the humans ileum, colon, and rectum. (Baseline/Time zero)
In the researchers’ words
Based on recent studies it is hypothesized that microplastics and nanoplastics (MNPs) are present in human's ileum, colon, and rectum and that their presence may have a correlation with Inflammatory Bowel Disease (IBD). This study is a cross-sectional, single-center, non-profit observational study.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | IBD |
| Lead sponsor | Pierpaolo Sileri |
| Enrollment | 102 (estimated) |
| Start date | 2025-06 |
| Primary completion (est.) | 2025-09-30 |
| First posted | 2024-07-29 |
| Last updated | 2025-05-02 |
| Official title | The Presence of Microplastics and Nanoplastics in the Humans Ileum, Colon, and Rectum and Their Relation With Inflammatory Bowel Disease (IBD): A Cross-sectional Observational Study |
| ClinicalTrials.gov ID | NCT06525558 |
Interventions
- Intestinal resection (Procedure)
This study does not add additional risks for patients as the resected specimen is collected during the surgery in accordance with standard clinical practice.
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients who will undergo any type of bowel surgery due to any type of clinical condition, as established by normal clinical practice, where colon, ileum and/or rectum resection is involved. * Patients aged ≥ 18 years. * Patients who have read, understood, accepted, and signed the informed consent to the study. * Female patients within and outside of childbearing age (breastfeeding women can be included in the study) Exclusion Criteria: * Patients aged < 18 years. * Pregnant women. * Patients who have not accepted informed consent.
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.